Alector (ALEC) Other Working Capital Changes (2018 - 2026)
Alector's (ALEC) quarterly Other Working Capital Changes came in at -$1.3 million in Q2 2026, down 536.82% year-over-year from $293029.6 in Q2 2025, and up 31.15% quarter-over-quarter from -$1.9 million in Q1 2026.
Analysis
Alector (ALEC) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Other Working Capital Changes for 9 consecutive years, with -$1.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Working Capital Changes fell 536.82% year-over-year to -$1.3 million in Q2 2026; TTM through Jun 2026 was -$4.6 million, a 3.13% decrease from a year earlier, with the FY2025 full-year figure at -$992000.0, up 82.05% from the prior year.
- Other Working Capital Changes was -$1.3 million for Q2 2026 at Alector, up from -$1.9 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $175.5 million in Q1 2022 and troughed at -$79.9 million in Q2 2022.
- A 5-year average of -$4.5 million and a median of -$7.1 million in 2025 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 353.68% in 2023, down 897.31% in 2023.
- Over 5 years, Other Working Capital Changes stood at $831000.0 in 2022, then surged by 276.05% to $3.1 million in 2023, then plunged by 123.74% to -$742000.0 in 2024, then surged by 255.12% to $1.2 million in 2025, then sank by 211.21% to -$1.3 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.3 million (Q2 2026), -$1.9 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.32 Mn |
| Jun 30, 2026 | -3.32 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Dec 31, 2025 | -6.24 Mn |
| Dec 31, 2025 | -6.24 Mn |
| Sep 30, 2025 | -3.26 Mn |
| Sep 30, 2025 | -3.26 Mn |
| Jun 30, 2025 | -7.87 Mn |
| Jun 30, 2025 | -7.87 Mn |
| Mar 31, 2025 | -3.67 Mn |
| Mar 31, 2025 | -3.67 Mn |
| Dec 31, 2024 | -54.24 Mn |
| Dec 31, 2024 | -54.24 Mn |
| Sep 30, 2024 | -15.34 Mn |
| Sep 30, 2024 | -15.34 Mn |
| Jun 30, 2024 | -15.08 Mn |
| Jun 30, 2024 | -15.08 Mn |
| Mar 31, 2024 | -15.89 Mn |
| Mar 31, 2024 | -15.89 Mn |